ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and to help enhance the doctor education; chronic condition management solution to hospitals, including hospital SaaS and proprietary artificial intelligence of things devices. It also offers pharmacy SaaS, which enables in-store, real-time online consultation, prescription, and risk pooling of outpatient services; and sells chronic condition related drugs based on its data insights in pharmacies, including information on inventory, sales, and shipments of prescription drugs. In addition, the company provides integrated in-and out-of-hospital solutions that connect hospitals and pharmacies; insurance brokerage and advertisement agent services; and sells pharmaceuticals, consumables, medical devices, and miscellaneous, as well as chronic condition related drugs. Further, it offers internet and e-commerce services; distributes insurance products; and produces and sells pharmaceutical products. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
Часто задаваемые вопросы
В каком секторе работает ClouDr Group Ltd (9955)?
ClouDr Group Ltd относится к сектору Здравоохранение.
Какова текущая цена акций ClouDr Group Ltd (9955)?
По последним данным, цена акций ClouDr Group Ltd составляет 0,40 HK$, предыдущее закрытие — 0,40 HK$. За последнюю торговую сессию акции ClouDr Group Ltd выросли на 0,01 HK$, что соответствует росту на 1,27%.
Выплачивает ли ClouDr Group Ltd (9955) дивиденды?
Нет, ClouDr Group Ltd не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у ClouDr Group Ltd (9955)?
У компании ClouDr Group Ltd бета 0.306, что указывает на более низкую волатильность по сравнению с рынком в целом.